The Intraoperative Neuromonitoring Market in US is being driven by Increasing number of surgeries that require IONM
The Intraoperative Neuromonitoring Market in US is expected to grow at a CAGR of 8.8% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 773.9 million. Intraoperative neuromonitoring (IONM) market in the US is witnessing an uptick in strategic acquisitions to bolster market presence and expand offerings. Notable transactions include MPOWERHealth's acquisition of Assure Neuromonitoring in March 2024. This deal aims to enhance MPOWERHealth's footprint in key markets and expand access to IONM services. Assure Neuromonitoring, a US-based company, provides IONM services. The integration is projected to bolster operational efficiency, support healthcare providers, and strengthen patient safety during surgeries. Another significant acquisition occurred in January 2023, when Natus Medical acquired Micromed Holding SAS, a neurophysiology solutions supplier. This strategic acquisition is expected to bolster Natus Medical's product portfolio and further expand its offerings in neurophysiology diagnostics and treatments.
Get more information on Intraoperative Neuromonitoring Market in US by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
182 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 8.8% |
Market growth 2025-2029 |
USD 773.9 million |
Market structure |
market_structure.ucfirst |
YoY growth 2024-2025(%) |
7.9 |
Key countries |
US |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
Intraoperative Neuromonitoring (IONM) in the US market encompasses neurophysiological monitoring techniques, such as intraoperative neurophysiologic monitoring, which ensure optimal functional outcomes during neurosurgical procedures. IONM is essential for functional neurosurgeries, including deep brain stimulation for Parkinson's disease, epilepsy surgery, and brain tumor resection. It also plays a crucial role in managing spinal cord injuries, peripheral neuropathies, nerve injuries, and neuromuscular disorders. IONM utilizes electrodiagnostic testing, functional mapping (cortical, spinal cord, nerve root), surgical navigation, and neurosurgical robotics for patient monitoring, continuous monitoring, data visualization, quality improvement, clinical decision support, outcomes research, patient engagement, education, informed consent, and ethical considerations.
The Intraoperative Neuromonitoring (IONM) market in the US is a significant segment of the global healthcare equipment industry. This market encompasses neurological monitoring solutions, including brain, nerve, spinal cord, and peripheral nerve monitoring, as well as evoked potentials. Technavio, a leading global technology research and consulting firm, positions the IONM market within the broader healthcare equipment market. This market comprises manufacturers of diagnostic equipment and devices used in various therapy areas, encompassing capital equipment, instruments, implants, accessories, and consumables. The global healthcare equipment market size is determined by the combined revenue generated by these manufacturers. The IONM market's growth is driven by the increasing number of surgeries requiring neurological monitoring, advancements in monitoring technologies, and the growing focus on patient safety and improved clinical outcomes.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted